-+ 0.00%
-+ 0.00%
-+ 0.00%
NeuroDex CEO Presents Blood-Based Biomarker Research at Arthur L. Haas Endowed Lecture
Share
Listen to the news
NeuroDex CEO Presents Blood-Based Biomarker Research at Arthur L. Haas Endowed Lecture
  • NeuroDex CEO Erez Eitan will deliver the sixth Arthur L. Haas Endowed Lecture at LSU Health New Orleans on Nov. 11, 2026.
  • His presentation will cover blood-based biomarker research in neurodegenerative diseases, focusing on potential applications in disease monitoring, treatment evaluation and clinical trials.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeuroDex Inc. published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending